Bioactive Components in Bovine Milk

Bioactive Components in Milk and Dairy Products

Volumn , Issue , 2009, Pages 13-42

  Korhonen, Hannu J ^a  

^a FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

Bioactive components in bovine milk; Bioactive components in milk; Bioactive peptides in dairy products and novel applications; Bioactive proteins and peptides; Bovine milk and colostrum source of natural bioactive components; Fractionation and isolation of bioactive milk proteins; Functional foods new approach in improving human nutrition and health; Immunoglobulins (Ig), carrying biological function of antibodies; Tapping innate bioactive milk components for new formulations; Technological and biological properties of milk and colostrum derived bioactive components

Indexed keywords

EID: 84859164931     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813821504.ch2     Document Type: Chapter

References (203)

1. Abd El-Salam, M.H., El-Shibini, S., and Buchheim, W. 1996. Characteristics and potential uses of the casein macropeptide. International Dairy Journal 6: 327-341.
2. Anonymous. 2005. Benefits and potential risks of the lactoperoxidase system of raw milk preservation. Report of an FAO/WHO technical meeting. FAO Headquarters, Rome, 28 November-2 December, 2005.
3. Ardö, Y., Lilbaek, H., Kristiansen, K.R, Zakora, M., and Otte, J. 2007. Identification of large phosphopeptides from β-casein that characteristically accumulate during ripening of the semi-hard cheese Herrgård. International Dairy Journal 17 :513-524.
4. Aro, A., Männist ö, S., Salminen, I., Ovaskainen, M-L., Kataja, V., and Uusitupa, M. 2000. Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutrition and Cancer 38 :151-157.
5. Ashar, M.N., and Chand, R. 2004. Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects. Milchwissenschaft 59: 363-366.
6. Avramis, C.A., Wang, H., McBride, B.W., Wright, T.C., and Hill, A.R. 2003. Physical and processing properties of milk, butter, and cheddar cheese from cows fed supplemental fish meal. Journal of Dairy Science 86: 2568-2576.
7. Belury, M.A. 2002. Dietary conjugated linoleic acid in health: Physiological effects and mechanisms of action. Annual Review of Nutrition 22 :505-531.
8. Bennett, L.E., Crittenden, R., Khoo, E., and Forsyth, S. 2005. Evaluation of immune-modulatory dairy peptide fractions. Australian Journal of Dairy Technology 60: 106-109.
9. Bernt, K.M., and Walker, W.A. 1999. Human milk as carrier of biochemical messages. Acta Pediatrica 430 (Suppl.): 7-41.
10. Billikiewicz, A., and Gaus, W. 2004. Colostrinin (a naturally occurring proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. Journal of Alzheimer's Disease 6: 17-26.
11. Bisig, W., Eberhard, P., Collomb, M., and Rehberger, B. 2007. Influence of processing on the fatty acid composition and the content of conjugated linoleic acid in organic and conventional dairy products-a review. Lait 87: 1-19.
12. Boots, J-W., and Floris, R. 2006. Lactoperoxidase:From catalytic mechanism to practical applications. International Dairy Journal 16: 1272-1276.
13. Bounous, G. 2000. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Research 20: 4785-4792.
14. Brody, E.P. 2000. Biological activities of bovine glycomacropeptide. British Journal of Nutrition 84: 39-S46.
15. Brück, W.M., Kelleher, S.L., Gibson, G.R., Nielsen, K.E., Chatterton, D.E., and Lönnerdal, B. 2003. rRNA probes used to quantify the effects of glycomacropeptide and α-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. Journal of Pediatric Gastroenterology and Nutrition 37 :273-280.
16. Bütikofer, U., Meyer, J., Sieber, R., and Wechsler, D. 2007. Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses. International Dairy Journal 17 :968-975.
17. Butler, J.E. 1994. Passive immunity and immunoglobulin diversity. International Dairy Federation Special Issue 9404: 14-50.
18. Campbell, B., and Petersen, W.E. 1963. Immune milk-a historical survey. Dairy Science Abstracts 25: 345-358.
19. Cashman, K.D. 2006. Milk minerals (including trace elements) and bone health. International Dairy Journal 16: 1389-1398.
20. Chabance, B., Marteau, P., Rambaud, J. C., Migliore-Samour, D., Boynard, M., Perrotin. P., Guillet, R., Jollés, P., and Fiat, A-M. 1998. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80 :155-165.
21. Chamba, J-F., Chardigny, J-M., Gnädig, S., Perreard, E., Chappaz, S., Rickert, R., Steinhart, H., and Séébédio, J-L. 2006. Conjugated linoleic acid (CLA) content of French Emmental cheese: effect of the season, region of production, processing and culinary preparation. Lait 86: 407-480.
22. Chatterton, D.E.W., Smithers, G., Roupas, P., and Brodkorb, A. 2006. Bioactivity of β-lactoglobulin and α-lactalbumin-technological implications for processing. International Dairy Journal 16 :1290-1240.
23. Chen, G-W., Tsai, J-S., and Sun Pan, B. 2007. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. International Dairy Journal 17 :641-647.
24. Chobert, J-M., El-Zahar, K., Sitohy, M., Dalgalarrondo , M., Métro, F., Choiset, Y., and Haertle, T. 2005. Angiotensin I-converting-enzyme (ACE)-inhibitory activity of tryptic peptides of ovine β-lactoglobulin and of milk yoghurts obtained by using different starters. Lait 85 :141-152.
25. Clare, D.A., Catignani, G.L., and Swaisgood, H.E. 2003. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Current Pharmaceutical Design 9: 1239-1255.
26. Clare, D.A., and Swaisgood, H.E. 2000. Bioactive milk peptides: A prospectus. Journal of Dairy Science 83: 1187-1195.
27. Collomb, M., Bütikofer, U., Sieber, R., Bosset, J.O., and Jeangros, B. 2001. Conjugated linoleic acid and trans fatty acid composition of cow's milk fat produced in lowlands and highlands. Journal of Dairy Research 68: 519-523.
28. Collomb, M., Schmid, A., Sieber, R., Wechsler, D., and Ryhänen, E-L. 2006. conjugated linoleic acids in milk fat: Variation and physiological effects. Internacional Dairy Journal 16 :1347-1361.
29. Cornish, J., Callon, K.E., Naot, D., Palmano, K.P., Banovic, T., Bava, U., Watson, M., Lin, J.M., Tong, P.C., Chen, Q., Chan, V.A., Reid, H.E., Fazzalari, N., Baker, H.M., Baker, E.N., Haggarty , N.W., Grey, A.B., and Reid, I.R. 2004. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145: 4366-4374.
30. Costa, E.L., Rocha Montijo, J.A., and Netto, F.M. 2007. Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates. Internacional Dairy Journal 17 :632-640.
31. Crittenden, R.G., and Bennett, L.E. 2005. Cow's milk allergy: A complex disorder. Journal of American College of Nutrition 24 (Suppl.6):582S-591S.
32. Donkor, O., Henriksson, A., Vasiljevic, T., and Shah, N.P. 2007. Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 86: 21-38.
33. Donnet-Hughes, A., Duc, N., Serrant, P., Vidal, K., and Schiffrin, E.J. 2000. Biaoctive molecules in milk and their role in health and disease: the role of transforming growth factor-β. Immunology and Cell Biology 78: 74-79.
34. Etzel, M.R. 2004. Manufacture and use of dairy protein fractions. Journal of Nutrition 134 :996S-1002S.
35. Farnaud, S., and Evans, R.W. 2003. Lactoferrin-a multifunctional protein with antimicrobial properties. Molecular Immunology 40: 395-405.
36. Ferreira, I.M.P.L.V.O., Pinho, O., Mota, M.V., Tavares, P., Pereira, A., Goncalves, M.P., Torres, D., Rocha, C., and Teixeira, J.A. 2007. Preparation of ingredients containing an ACE-inhibitory peptide by tryptic hydrolysis of whey protein concentrates. International Dairy Journal 17 :481-487.
37. FitzGerald, R.J., and Meisel, H. 2003. Milk protein hydrolysates and bioactive peptides. In Advanced Dairy Chemistry. Vol. 1: Proteins, edited by P.F. Fox and P.L.H. McSweeney. Kluwer Academic/Plenum Publishers, New York. pp. 675-698.
38. FitzGerald, R.J., and Murray, B.A. 2006. Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 59: 118-125.
39. FitzGerald, R.J., Murray, B.A., and Walsh, D.J. 2004. Hypotensive peptides from milk proteins. Journal of Nutrition 134: 980S-988S.
40. Floris, R., Recio, I., Berkhout, B., and Visser, S. 2003. Antibacterial and antiviral effects of milk proteins and derivatives thereof. Current Pharmaceutical Design 9: 1257-1275.
41. Foegeding, E.A., Davis, J.P., Doucet, D., and McGuffey, M.K. 2002. Advances in modifying and understanding whey protein functionality. Trends in Food Science and Technology 13 :151-159.
42. Fong, B.Y., Norris, C.S., and MacGibbon, A.K.H. 2007. Protein and lipid composition of bovine milk-fat-globule-membrane. International Dairy Journal 17: 275-288.
43. Fong, B.Y., Norris, C.S., and Palmano, K.M. 2008. Fractionation of bovine whey proteins and characterization by proteomic characteristics. International Dairy Journal 18: 23-46.
44. Fox, P.F., and Kelly, A.L. 2006. Indigenous enzymes in milk: Overview and historical aspects-Part 1. International Dairy Journal 16: 500-516.
45. Fuglsang, A., Rattray, F.P., Nilsson, D., and Nyborg, N.C.B. 2003. Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie van Leeuwenhoek. 83: 27-34.
46. Gagnaire, V., Molle, D., Herrouin, M., and Leonil, J. 2001. Peptides identified during Emmental cheese ripening: origin and proteolytic systems involved. Journal of Agricultural and Food Chemistry 49: 4402-4413.
47. Gauthier, S.F., Pouliot, Y., and Maubois, J-L. 2006a. Growth factors from bovine milk and colostrum :composition, extraction and biological activities. Lait 86: 125.
48. Gauthier, S.F., Pouliot, Y., and Saint-Sauveur, D. 2006b. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. International Dairy Journal 16: 1315-1323.
49. German, J.B., Dillard, C.J., and Ward, R.E. 2002. Bioactive components in milk. Current Opinion in Clinical Metabolic Care 5: 653-658.
50. Gerson, C., Sabater, J., Scuri, M., Torbati, A., Coffey, R., Abraham, J., et al. 2000. The lactoperoxidase system functions in bacterial clearance of airways. American Journal of Respiratory Cell and Molecular Biology 22: 665-671.
51. Gill, H.S., and Cross, M.L. 2000. Anticancer properties of bovine milk. British Journal of Nutrition 84 (Suppl.1): S161-S166.
52. Gobbetti, M., Minervini, F., and Rizzello, C.G. 2004. Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. International Journal of Dairy Technology 57 :172-188.
53. Gobbetti, M., Minervini, F., and Rizzello, C.G. 2007. Bioactive peptides in dairy products. In Handbook of Food Products Manufacturing:Health, Meat, Milk, Poultry, Seafood, and Vegetables, edited by Y.H. Hui. John Wiley & Sons, Inc., Hoboken, NJ. pp. 489-517.
54. Gómez-Ruiz, J.A., Ramos, M., and Recio, I. 2002. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. International Dairy Journal 12: 697-706.
55. Gopal, P., and Gill, H.S. 2000. Oligosaccharides and glycoconjugates in bovine milk and colostrum. British Journal of Nutrition 84 (Suppl.1):S69-S74.
56. Griinari, J.M., Corl, B.A., Lacy, S.H., Choinard, P.Y., Nurmela, K.V., and Bauman, D.E. 2000. Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by δ 9-desaturase. Journal of Nutrition 130: 2285-2291.
57. Grosvenor, C.E., Picciano, M.F., and Baumrucker, C.R. 1993. Hormones and growth factors in milk. Endocrine Reviews 14: 710-728.
58. Gustafson, D.R., McMahon, D.J., Morrey, J., and Nan, R. 2001. Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP). Appetite 36: 157-163.
59. Ha, E., and Zemel, M.B. 2003. Functional properties of whey, whey components, and essential amino acids: mechanisms underlying health benefits for active people. Journal of Nutritional Biochemistry 14: 251-258.
60. Hartmann, R., and Meisel, H. 2007. Food-derived peptides with biological activity: from research to food applications. Current Opinion in Biotechnology 18: 1-7.
61. Hata, Y., Yamamoto, M., Ohni, H., Nakajima, K., Nakamura, Y., and Takano, T. 1996. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 64: 767-771.
62. Hoerr, R.A., and Bostwick, E.F. 2002. Commercializing colostrum-based products: a case study of GalaGen. Bulletin of International Dairy Federation 375: 33-46.
63. Ip, M.M., Masso-Welch, P.A., and Ip, C. 2003. Prevention of mammary cancer with conjugated linoleic acid: Role of the stroma and the epithelium. Journal of Mammary Gland and Neoplasia 8 :103-118.
64. Jauhiainen, T., Vapaatalo, H., Poussa, T., Kyrönpalo, S., Rasmussen, M., and Korpela, R. 2005. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. American Journal of Hypertension 18: 1600-1605.
65. Jensen, R.G. 2002. The composition of bovine milk lipids: January 1995-December 2000. Journal of Dairy Science 85: 295-350.
66. Jouan, P-N., Pouliot, Y., Gauthier, S.F., and Laforest , J-P. 2006. Hormones in milk and milk products:A survey. International Dairy Journal 16 :1408-1414.
67. Kawakami, H. 2005. Biological significance of milk basic protein (MBP) for bone health. Food Science and Technology Research 11: 1-8.
68. Kelly, G.S. 2003. Bovine colostrums: A review of clinical uses. Alternative Medicine Review 8 :378-394.
69. Kelly, P.M., and McDonagh, D. 2000. Innovative dairy ingredients. The World of Food Ingredients. Oct/Nov: 24-32.
70. Kilara, A., and Panyam, D. 2003. Peptides from milk proteins and their properties. Critical Reviews in Food Science and Nutrition 43 :607-633.
71. Kilpi, E.E-R., Kahala, M.M., Steele, J.L., Pihlanto, A.M., and Joutsjoki, V.V. 2007. Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. International Dairy Journal 17: 976-984.
72. King, Jr., J.C., Cummings, G.E., Guo, N., Trivedi, L., Readmond, B.X., Keane, V., Feigelman, S., and de Waard, R. 2007. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. Journal of Pediatric Gastroenterology and Nutrition 44 :245-251.
73. Kitts, D.D., and Weiler, K. 2003. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 9: 1309-1323.
74. Konrad, G., and Kleinschmidt, T. 2008. A new method for isolation of native α-lactalbumin from sweet whey. International Dairy Journal 18 :23-46.
75. Korhonen, H. 1977. Antimicrobial factors in bovine colostrum. Journal of the Scientific Agricultural Society of Finland. 49: 434-447.
76. Korhonen, H. 2002. Technology options for new nutritional concepts. International Journal of Dairy Technology 55: 79-88.
77. Korhonen, H., and Marnila, P. 2006. Bovine milk antibodies for protection against microbial human diseases. In Nutraceutical Proteins and Peptides in Health and Disease, edited by Y. Mine and S. Shahidi. Taylor & Francis Group, Boca Raton, FL. pp. 137-159.
78. Korhonen, H., Marnila, P., and Gill, H. 2000. Bovine milk antibodies for health: a review. British Journal of Nutrition 84 (Suppl.1): 135-146.
79. Korhonen, H., and Pihlanto, A. 2003. Food-derived bioactive peptides-opportunities for designing future foods. Current Pharmaceutical Design 9 :1297-1308.
80. Korhonen, H., and Pihlanto, A. 2006. Bioactive peptides: Production and functionality. International Dairy Journal 16 :945-960.
81. Korhonen, H., and Pihlanto, A. 2007a. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Current Pharmaceutical Design 13: 829-843.
82. Korhonen, H., and Pihlanto, A. 2007b. Bioactive peptides from food proteins. In: Handbook of Food Products Manufacturing:Health, Meat, Milk, Poultry, Seafood, and Vegetables, edited by Y.H. Hui. John Wiley & Sons, Inc. Hoboken, NJ. pp. 5-38.
83. Korhonen, H., Pihlanto-Leppälä, A., Rantamäki, P., and Tupasela, T. 1998. Impact of processing on bioactive proteins and peptides. Trends in Food Science and Technology 9: 307-319.
84. Krissansen, G.W. 2007. Emerging health properties of whey proteins and their clinical implications. Journal of American College of Nutrition 26 :713S-723S.
85. Kulozik, U., Tolkach, A., Bulca, S., and Hinrichs, J. 2003. The role of processing and matrix design in development and control of microstructures in dairy food production-a survey. International Dairy Journal 13: 621-630.
86. Kunz, C., and Rudloff, S. 2006. Health promoting aspects of milk oligosaccharides. International Dairy Journal 16: 1341-1346.
87. Kunz, C., Rudloff, S., Baier, W., Klein, N., and Strobel, S. 2000. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annual Review of Nutrition 20 :699-722.
88. Kussendrager, K.D., and van Hooijdonk, A.C.M. 2000. Lactoperoxidase: physico-chemical properties, occurrence, mechanism of action and applications. British Journal of Nutrition 84 (Suppl.1):19-25.
89. Larsen, T.M., Tourbro, S., and Astrup, A. 2003. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: Evidence from animal and human studies. Journal of Lipid Research 44: 2234-2241.
90. Larsson, S.C., Bergkvist, L., and Wolk, A. 2005. High-fat dairy food and conjugated linoleic acid intakes in relation to colorectal cancer incidence in the Swedish mammography cohort. American Journal Clinical Nutrition 82: 894-900.
91. Lee, K.W., and Lee, H.J. 2005. Role of the conjugated linoleic acid in the prevention cancer. Critical Reviews in Food Science and Nutrition 45 :135-144.
92. Lindmark-Månsson, H., Timgren, A., Aden, G., and Paulsson, M. 2005. Two-dimensional gel electrophoresis of proteins and peptides in bovine milk. International Dairy Journal 15: 111-121.
93. Lönnerdal, B. 2003. Nutritional and physiologic significance of human milk proteins. American Journal of Clinical Nutrition 77: 1537S-1543S.
94. López-Expósito, I., Quirós, A., Amigo, L., and Recio, I. 2007. Casein hydrolysates as a source of antimicrobial, antioxydant and antihypertensive peptides. Lait 87: 241-249.
95. López-Expósito, I., and Recio, I. 2006. Antibacterial activity of peptides and folding variants from milk proteins. International Dairy Journal 16 :1294-1305.
96. López-Fandiño, R., Otte, J., and Van Camp, J. 2006. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal 16: 1277-1293.
97. Lorenzen, P.C., and Meisel, H. 2005. Influence of trypsin action in yoghurt milk on the release of caseinophosphopeptide-rich fractions and physical properties of the fermented products. International Journal of Dairy Technology 58 :119-124.
98. Lozano, J.M., Giraldo, G.I., and Romero, C.M. 2008. An improved method for isolation of β-lactoglobulin. International Dairy Journal 18 :55-63.
99. Luhovyy, B.L., Akhavan, T., and Anderson, G.H. 2007. Whey proteins in the regulation of food intake and satiety. Journal of American College of Nutrition 26: 704S-712S.
100. Madureira, A.R, Pereira, C.I., Gomes, A.M.P., Pintado, M.E., and Malcata, F.X. 2007. Bovine whey proteins-Overview on their main biological properties. Food Research International 40 :1197-1211.
101. Maes, W., van Camp, J., Vermeirssen, V., Hemeryck, M., Ketelslegers, J.M., Schrezenmeier, J., van Oostveldt, P., and Huyghebaert, A. 2004. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regulatory Peptides 118 :105-109.
102. Manso, M.A., and López-Fandiño, R. 2004. κ-Casein macropeptides from cheese whey:Physicochemical, biological, nutritional, and technological features for possible uses. Food Reviews International 20: 329-355.
103. Markus, C.R., Olivier, B., and de Haan, E.H. 2002. Whey protein rich in α-lactalbumin increases the ratio of plasma tryptophan to the sum of the large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. American Journal of Clinical Nutrition 75: 1051-1056.
104. Markus, C.R., Olivier, B., Pamhuysen, G.E., Van der Gugten, J., Alles, M-S., Tuiten, A., et al. 2000. The bovine protein α-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration and improves mood under stress. American Journal of Clinical Nutrition 75 :1051-1056.
105. Marshall, K. 2004. Therapeutic applications of whey proteins. Alternative Medicine Review 9 :136-156.
106. Martin, M.J., Martin-Sosa, S., Garcia-Pardo, I.A., and Hueso, P. 2001. Distribution of bovine sialoglycoconjugates during lactation. Journal of Dairy Science 84: 995-1000.
107. Matar, C., LeBlanc, J.G., Martin, L., and Perdigón, G. 2003. Biologically active peptides released in fermented milk: Role and functions. In Handbook of Fermented Functional Foods. Functional Foods and Nutraceuticals Series, edited by E.R. Farnworth. CRC Press, Boca Raton, FL. pp. 177-201.
108. Mather, I.H. 2000. A review and proposed nomenclature for major proteins of the milk-fat globule membrane. Journal of Dairy Science 83:203-247.
109. Matsumoto, H., Shimokawa, Y., Ushida, Y., Toida, T., and Hayasawa, H. 2001. New biological function of bovine α-lactalbumin: Protective effect against ethanol-and stress-induced gastric mucosal injury in rats. Bioscience, Biotechnology and Biochemistry 65: 1104-1111.
110. McDonagh, D., and FitzGerald, R.J. 1998. Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations. International Dairy Journal 8: 39-45.
111. McIntosh, G.H,, Royle, P.J., Le Leu, R.K., Regester, G.O., Johnson, M.A., Grinsted, R.L., Kenward, R.S., and Smithers, G. 1998. Whey proteins as functional ingredients? International Dairy Journal 8: 425-434.
112. Mehra, R., and Kelly, P. 2006. Milk oligosaccharides:Structural and technological aspects. International Dairy Journal 16: 1334-1340.
113. Mehra, R., Marnila, P., and Korhonen, H. 2006. Milk immunoglobulins for health promotion. International Dairy Journal 16: 1262-1271.
114. Meisel, H. 1998. Overview on milk protein-derived peptides. International Dairy Journal 8: 363-373.
115. Meisel, H.. 2005. Biochemical properties of peptides encrypted in bovine milk proteins. Current Medical Chemistry 12: 1905-1919.
116. Meisel, H., and FitzGerald, R.J. 2000. Opioid peptides encrypted in intact milk protein sequences. British Journal of Nutrition 84 (Suppl.1): 27-31.
117. Meisel, H., and FitzGerald, R.J. 2003. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Current Pharmaceutical Design 9 :1289-1295.
118. Mensink, R.P. 2006. Dairy products and the risk to develop type 2 diabetes or cardiovascular disease. International Dairy Journal 16: 1001-1004.
119. Mero, A., Kähkónen, J., Nykónen, T., Parviainen, T., Jokinen, I., Takala, T., Nikula, T., Rasi, S., and Leppäluoto, J. 2002. IGF-1, IgA and IgG responses to bovine colostrum supplementation during training. Journal of Applied Physiology 93 :732-739.
120. Michaelidou, A., and Steijns, J. 2006. Nutritional and technological aspects of minor bioactive components in milk and whey: Growth factors, vitamins and nucleotides. International Dairy Journal 16: 1421-1426.
121. Mizuno, S., Nishimura, S., Matsuura, K., Gotou, T., and Yamamoto, N. 2004. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. Journal of Dairy Science 87: 3183-3188.
122. Mullally, M. M., Meisel, H., and FitzGerald, R.J. 1997. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Letters 402: 99-101.
123. Mulvihill, D.M., and Ennis, M.P. 2003. Functional milk proteins: production and utilization. In Advances in Dairy Chemistry, Vol 1: Proteins, edited by P.F. Fox and P.L.H. McSweeney. Kluwer Academic/Plenum Publishers, New York. pp. 1175-1228.
124. Murakami, M., Tonouchi, H., Takahashi, R., Kitazawa , H., Kawai, Y., Negishi, H., et al. 2004. Structural analysis of a new anti-hypertensive peptide (β-lactosin B) isolated from a commercial whey product. Journal of Dairy Science 87 :1967-1974.
125. Murray, B.A., and Fitzgerald, R.J. 2007. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Current Pharmaceutical Design 13: 773-91.
126. Nagaoka, S., Futamura, Y., Miwa, K., Awano, T., Yamauchi, K., Kanamaru, Y., Tadashi, K., and Kuwata, T. 2001. Identification of novel hypocholesterolemic peptides derived from bovine milk β-lactoglobulin. Biochemical and Biophysical Research Communications 218: 11-17.
127. Nakamura, Y., Yamamoto, M., Sakai, K., Okubo, A., Yamazaki, S., and Takano, T. 1995. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of Dairy Science 78: 777-783.
128. O'Donnell, R., Holland, J.W., Deeth, H.C., and Alewood, P. 2004. Milk proteomics. International Dairy Journal 14: 1013-1023.
129. Ong, L., Henriksson, A., and Shah, N.P. 2007. Angiotensin converting enzyme-inhibitory activity in cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Lait 87 :149-165.
130. Otte, J., Shalaby, S.M., Zakora, M., Pripp, A.H., and El-Shabrawy, S.A. 2007. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates:Effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 17 :488-503.
131. Pakkanen, R., and Aalto, J. 1997. Growth factors and antimicrobial factors of bovine colostrum. International Dairy Journal 7: 285-297.
132. Pan, Y., Lee, A., Wan, J., Coventry, M.J., Mixchalski , W.P., Shiell, B., and Roginski, H. 2006. Antiviral properties of milk proteins and peptides. International Dairy Journal 16: 1252-1261.
133. Pan, Y., Rowney, M., Guo, P., and Hobman, P. 2007. Biological properties of lactoferrin: an overview. Australian Journal of Dairy Technology 62: 31-42.
134. Pariza, M.W., Park, Y., and Cook. M.E. 2001. The biological active isomers of conjugated linoleic acid. Progress in Lipid Research 40 :283-298.
135. Park, Y., Storkson, J.M., Albright, K.J., Liu, W., and Pariza, M.W. 1999. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34: 235-241.
136. Parodi, P.W. 1998. A role for milk proteins in cancer prevention. Australian Journal of Dairy Technology 53: 37-47.
137. Parodi, P.W. 1999. Conjugated linoleic acid and other anti-carcinogenic agents of bovine milk fat. Journal of Dairy Science 82: 1339-1349.
138. Parodi, P.W. 2003. Anti-cancer agents in milkfat. Australian Journal of Dairy Technology 58: 114-118.
139. Parodi, P.W. 2004. Milk fat in human nutrition. Australian Journal of Dairy Technology 59: 3-59.
140. Pettus, B.J., Chalfant, C.E., and Hannun, Y.A. 2004. Shingolipids in inflammation: Roles and implications. Current Molecular Medicine 4 :405-418.
141. Pfeuffer, M., and Schrezenmeir, J. 2006a. Milk and the metabolic syndrome. Obesity reviews 8 :109-118.
142. Pfeuffer, M., and Schrezenmeir, J. 2006b. Impact of trans fatty acids of ruminant origin compared with those from partially hydrogenated vegetable oils on CHD risk. International Dairy Journal 16: 1383-1388.
143. Pihlanto, A. 2006. Antioxidative peptides derived from milk proteins. International Dairy Journal 16: 1306-1314.
144. Pihlanto, A., and Korhonen, H. 2003. Bioactive peptides and proteins. In Advances in Food and Nutrition Research, edited by S.L. Taylor. Elsevier Inc., San Diego, CA. pp. 175-276.
145. Pihlanto-Leppälä, A., Rokka, T., and Korhonen, H. 1998. Angiotensin I-converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal 8: 325-331.
146. Playford, R.J., Floyd, D.N., Macdonald, C.E., Calnan, D.P., Adenekan, R.O., Johnson, W., Goodlad, R.A., and Marchbank, T. 1999. Bovine colostrum is a health food supplement which prevents NSAID induced gut damage. Gut 44 :653-658.
147. Playford, R.J., MacDonald, C.E., and Johnson, W. S. 2000. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. American Journal of Clinical Nutrition 72: 5-14.
148. Playne, M.J., Bennett, L.E., and Smithers, G.W. 2003. Functional dairy foods and ingredients. Australian Journal of Dairy Technology 58 :242-264.
149. Pouliot, Y., and Gauthier, S.F. 2006. Milk growth factors as health products: Some technological aspects. International Dairy Journal 16: 1415-1420.
150. Pouliot, Y., Gauthier, S.F., and Groleau, P.E. 2006. Membrane-based fractionation and purification strategies for bioactive peptides. In Nutraceutical Proteins and Peptides in Health and Disease, edited by Y. Mine and F. Shahidi CRC, Taylor & Francis Group, Boca Raton, FL. pp. 639-658.
151. Quirós, A., Hernández-Ledesma, B., Ramos, M., Amigo, L., and Recio, I. 2005. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. Journal of Dairy Science 88: 3480-3487.
152. Quirós, A., Ramos, M., Muguerza, B., Delgado, M., Miguel, M., Alexaindre, A., and Recio, I. 2007. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 17: 33-41.
153. Reiter, B., and Härnulv, G. 1984. Lactoperoxidase antibacterial system: natural occurrence, biological functions and practical applications. Journal of Food Protection 47: 724-732.
154. Reiter, B., and Oram, J.D. 1967. Bacterial inhibitors in milk and other biological fluids. Nature 216 :328-330.
155. Rhoades, J.R., Gibson, G.R., Formentin, K., Beer, M., Greenberg, N., and Rastall, R.A. 2005. Caseinoglycomacropeptide inhibits adhesion of pathogenic Escherichia coli strains to human cells in culture. Journal of Dairy Science 88: 3455-3459.
156. Rombaut, R., and Dewettinck, K. 2006. Properties, analysis and purification of milk polar lipids. International Dairy Journal 16: 1362-1373.
157. Roufik, S., Gauthier, S.F., and Turgeon, S.L. 2006. In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. International Dairy Journal 16: 294-302.
158. Rowan, A.M., Haggarty, N.W., and Ram, S. 2005. Milk bioactives: discovery and proof of concept. Australian Journal of Dairy Technology 60 :114-120.
159. Ryhänen, E.L., Pihlanto-Leppälä, A., and Pahkala, E. 2001. A new type of ripened; low-fat cheese with bioactive properties. International Dairy Journal 11: 441-447.
160. Ryhänen, E.-L., Tallavaara, K., Griinari, J.M., Jaakkola, S., Mantere-Alhonen, S., and Shingfield, K. 2005. Production of conjugated linoleic acid enriched milk and dairy products from cows receiving grass silage supplemented with a cereal-based concentrate containing rapeseed oil. International Dairy Journal 15 :207-217.
161. Saito, T., Nakamura, T., Kitazawa, H., Kawai, Y., and Itoh, T. 2000. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. Journal of Dairy Science 83 :1434-1440.
162. Scammel, A.W. 2001. Production and uses of colostrum. Australian Journal of Dairy Technology 56 :74-82.
163. Schaafsma, G. 2006a. Health issues of whey proteins:1. Protection of lean body mass. Current Topics in Nutraceutical Research 4: 113-122.
164. Schaafsma, G. 2006a. Health issues of whey proteins: 2. Weight management. Current Topics in Nutraceutical Research 4: 123-126.
165. Schlimme, E., Martin, D., and Meisel, H. 2000. Nucleosides and nucleotides: natural bioactive substances in milk and colostrum. British Journal of Nutrition 84 (Suppl.1): S59-S68.
166. Scholz-Ahrens, K.E., and Schrezenmeir, J. 2006. Milk minerals and the metabolic syndrome. International Dairy Journal 16: 1399-1407.
167. Scrutton, H., Carbonnier, A., Cowen, P.J., and Harmer, C. 2007. Effects of (alpha)-lactalbumin on emotional processing in healthy women. Journal of Psychopharmacology (ref. CERIN 259: 33771N, 2007).
168. Seifu, E., Buys, E.M., and Donkin, E.F. 2005. Significance of the lactoperoxidase system in the dairy industry and its potential applications: a review. Trends in Food Science and Technology 16: 137-154.
169. Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 77: 326-330.
170. Shah, N.P. 2000. Effects of milk-derived bioactives:an overview. British Journal of Nutrition 84 :S3-S10.
171. Shin, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., and Imoto, I. 2002. Susceptibility of Helicobacter pylori and its urease activity to the peroxidase-hydrogen peroxide-thiocyanate antimicrobial system. Journal of Medical Microbiology 51: 231-237.
172. Shingfield, K.J., Reynolds, C.K., Hervas, G., Griinari , J.M., Grandison, A.S., and Beever, D.E. 2006. Examination of the persistency of milk fatty acid composition responses to fish oil and sunflower oil in the diet of dairy cows. Journal of Dairy Science 89: 714-732.
173. Sieber, R., Collomb, M., Aeschlimann, A., Jelen, P., and Eyer, H. 2004. Impact of microbial cultures on conjugated linoleic acid in dairy products-a review. International Dairy Journal 14: 1-15.
174. Silva, S.V., and Malcata, F.X. 2005. Caseins as source of bioactive peptides. International Dairy Journal 15: 1-15.
175. Singh, T.K., Fox, P.F., and Healy, A. 1997. Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of cheddar cheese. Journal of Dairy Research 64 :433-443.
176. Sipola, M., Finckenberg, P., Korpela, R., Vapaatalo, H., and Nurminen, M-L. 2002. Effect of long-term intake of milk products on blood pressure in hypertensive rats. Journal of Dairy Research 69 :103-111.
177. Smacchi, E., and Gobbetti, M. 1998. Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria; Pseudomonas fluorescens ATCC 948, and to the angiotensin I-converting enzyme. Enzyme Microbiology and Technology 22: 687-694.
178. Smilowitz, J.T., Dillard, C.J., and German, J.B. 2005. Milk beyond essential nutrients: the metabolic food. Australian Journal of Dairy Technology 60: 77-83.
179. Smithers, G.W. 2004. Isolation of growth factors from whey and their application in the food and biotechnology industries-a brief review. Bulletin of the International Dairy Federation 389 :16-19.
180. Smithers, G.W., Ballard, F.J., Copeland, A.D., De Silva, K.J., Dionysius, D.A., Francis, G.L., Goddard, C., Grieve, P.A., McIntosh, G.H., Mitchell, I.R., Pearce, R.J., and Regester, G.O. 1996. New opportunities from the isolation and utilization of whey proteins. Journal of Dairy Science 79: 1454-1459.
181. Sokolowska, A., Bednarz, R., Pacewicz, M., Georgiades , J.A., Wilusz, T., and Polanowski, A. 2008. Colostrum from different mammalian species-A rich source of colostrinin. International Dairy Journal 18: 204-209.
182. Spitsberg, V.L. 2005. Bovine milk fat globule membrane as a potential nutraceutical. Journal of Dairy Science 88: 2289-2294.
183. Steijns, J.M. 2001. Milk ingredients as nutraceuticals. International Journal of Dairy Technology 54: 81-88.
184. Struff, W.G., and Sprotte, G. 2007. Bovine colostrum as a biologic in clinical medicine: a review. International Journal of Clinical Pharmacology and Therapeutics 45: 193-202.
185. Sütas, Y., Soppi, E., Korhonen, H., Syväoja, E-L., Saxelin, M., Rokka, T., and Isolauri, E. 1996. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. Journal of Allergy and Clinical Immunology 98: 216-224.
186. Tamura, Y. 2004. Production and application of bovine lactoferrin. Bulletin of the International Dairy Federation 389: 64-68.
187. Teraguchi, S., Wakabayashi, H., Kuwata, H., Yamauchi, K., and Tamura, Y. 2004. Protection against infections by oral lactoferrin: evaluation in animal models. Biometals 17: 231-234.
188. Terpstra, A.H.M. 2004. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: An overview of the literature. American Journal of Clinical Nutrition 79 :352-361.
189. Thomä-Worringer, C., Sörensen, J., and López-Fandiño, R. 2006. Health effects and technological features of caseinomacropeptide. International Dairy Journal 16: 1324-1333.
190. Tripathi, V., and Vashishtha, B. 2006. Bioactive compounds of colostrum and its application. Food Reviews International 22: 225-244.
191. Ushida, Y., Shimokawa, Y., Matsumoto, H., Toida, T., and Hayasawa, H. 2003. Effects of bovine α-lactalbumin on gastric defense mechanisms in naive rats. Bioscience, Biotechnology and Biochemistry 67: 577-583.
192. Valtonen, M., Niskanen, L., Kangas, A.P., and Koskinen, T. 2005. Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects. Nordic Journal of Psychiatry 59: 217-221.
193. Virtanen, T., Pihlanto, A., Akkanen, S., and Korhonen, H. 2006. Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. Journal of Applied Microbiology 102 :106-115, 2006.
194. Wakabayashi, H., Yamauchi, K., and Takase, M. 2006. Lactoferrin research, technology and applications. International Dairy Journal 16 :1241-1251.
195. Walzem, R.L., Dillard, C.J., and German, J.B. 2002. Whey components: millennia of evolution create functionalities for mammalian nutrition: what we know and what we may be overlooking. Critical Reviews in Food Science and Nutrition 42 :353-375.
196. Wang, B., Brand-Miller, J., McVeagh, P., and Petocz, P. 2001. Concentration and distribution of sialic acid in human milk and infant formulas. American Journal of Clinical Nutrition 74 :510-515.
197. Weiner, C., Pan, Q., Hurtig, M., Boren, T., Bostwick, E., and Hammarström, L. 1999. Passive immunity against human pathogens using bovine antibodies. Clinical and Experimental Immunology 116: 193-205.
198. Wheeler, T.T., Hodgkinson, A.J., Prosser, C.G., and Davis, S.R. 2007. Immune components of colostrum and milk-a historical perspective. Journal of Mammary Gland Biology and Neoplasia 12 :237-247.
199. Yalcin, A.S. 2006. Emerging therapeutic potential of whey proteins and peptides. Current Pharmaceutical Design 12: 1637-1643.
200. Yamamoto, N., Ejiri, M., and Mizuno, S. 2003. Biogenic peptides and their potential use. Current Pharmaceutical Design 9: 1345-1355.
201. Yvon, M., Beucher, S., Guilloteau, P., Le Huerou-Luron, I., and Corring, T. 1994: Effects of caseinomacropeptide (CMP) on digestion regulation. Reproduction and Nutrition Development 34 :527-537.
202. Zemel, M.B. 2004. Role of calcium and dairy products in energy portioning and weight management. American Journal of Clinical Nutrition 79 (Suppl.1): 907S-912S.
203. Zimecki, M., and Kruzel, M.L. 2007. Milk-derived proteins and peptides of potential therapeutic and nutritive value. Journal of Experimental Therapy and Oncology 6: 89-106.